📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

RUNX1/ETO and mutant KIT both contribute to programming the transcriptional and chromatin landscape in t(8;21) acute myeloid leukemia. (2020)

First Author: Chin PS

Attributed to: Finding therapeutic targets in FLT3-ITD AML using a systems biology approach funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.exphem.2020.10.005

PubMed Identifier: 33152396

Publication URI: http://europepmc.org/abstract/MED/33152396

Type: Journal Article/Review

Volume: 92

Parent Publication: Experimental hematology

ISSN: 0301-472X